Effects of Exercise Training on Endothelial Function, Inflammation, Arterial Stiffness and Autonomic Function in CAD
Primary Purpose
Coronary Artery Disease
Status
Completed
Phase
Not Applicable
Locations
Portugal
Study Type
Interventional
Intervention
Exercise-based cardiac rehabilitation program
Sponsored by
About this trial
This is an interventional treatment trial for Coronary Artery Disease focused on measuring Myocardial infarction, Autonomic function, Arterial Stiffness, Endothelial function, Inflammation, Rehabilitation program, Exercise
Eligibility Criteria
Inclusion Criteria:
- acute myocardial infarction
Exclusion Criteria:
- ventricular tachyarrhythmia
- uncontrolled hypertension (systolic blood pressure >180 mmHg or diastolic blood pressure >100 mmHg)
- significant valvular disease
- unstable angina pectoris
- reduced left ventricular function (ejection fraction < 45%)
- abnormal hemodynamic response
- myocardial ischemia and/or severe ventricular arrhythmias during baseline exercise testing
- uncontrolled metabolic disease (e.g. uncontrolled diabetes or thyroid disease)
- presence of pulmonary and renal co-morbidities
- peripheral artery disease and/or orthopedic limitations
Sites / Locations
- Centro Hospitalar de Vila Nova de Gaia/Espinho
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Experimental group
Control group
Arm Description
Patients undergoing the exercise-based cardiac rehabilitation program (intervention)
Usual medical care
Outcomes
Primary Outcome Measures
Autonomic Function
Autonomic function will be assessed by resting heart rate variability, heart rate recovery after maximal exercise and circulating levels of norepinephrine and epinephrine.
Secondary Outcome Measures
Arterial Stiffness
Arterial Stiffness will be assessed by carotid-femoral pulse wave velocity and the aortic augmentation index.
Endothelial Function
Using commercially available assay kits (R&D Systems, Minneapolis, MN, USA), the serum levels of sICAM-1 and sVCAM-1 will be measured in serum by an enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions and read at 450 nm using a microplate reader (Labsystems iEMS MF controlled by Ascent software v. 2.4, Dynex Labsystems).
Cardiorespiratory Fitness
Maximal or symptom-limited treadmill exercise testing will be conducted using the modified Bruce protocol.
Inflammatory Biomarkers
Using commercially available assay kits (R&D Systems, Minneapolis, MN, USA), the serum levels of CRP, IL-10 and IL-6 will be measured in serum by an enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions and read at 450 nm using a microplate reader (Labsystems iEMS MF controlled by Ascent software v. 2.4, Dynex Labsystems).
Anthropometrics
Height and weight measurements will be assessed using a standard wall-mounted stadiometer and portable digital beam scale (SECA, 708), respectively. Body mass index will be calculated from the ratio of weight (kg) to squared height (m2). Percentage of fat mass will be estimated by bioelectrical impedance analysis (BC-532, Tanita, Tokyo, Japan).
Blood Pressure
Resting systolic and diastolic blood pressure will be measured using a digital automatic blood pressure monitor (Omron Pressmate BP10, Omron Healthcare Co., Ltd, Kyoto, Japan).
Dietary Intake
Dietary intake will be assessed using a 4-day food diary as representative of the usual intake. Patients will be asked to provide detailed information concerning the food and beverages intake for four days (Sunday and 3-week days).
Daily Physical Activity
Physical activity will be objectively measured for 7 consecutive days using the ActiGraph accelerometer (model GT1M, Florida, USA).
Biochemical Parameters
Fasting plasma glucose, total cholesterol, high-density lipoprotein cholesterol, triglycerides, and HbA1c will be measured by enzymatic methods (912 automatic analyzer, Roche Diagnostic, Basel, Switzerland). Low-density lipoprotein cholesterol will be calculated using the Friedewald equation, except if triglycerides > 400 mg/dL.
Full Information
NCT ID
NCT01432639
First Posted
September 7, 2011
Last Updated
June 5, 2013
Sponsor
Universidade do Porto
Collaborators
Centro Hospitalar de Vila Nova de Gaia/Espinho, Research Center in Physical Activity, Health and Leisure, Portugal
1. Study Identification
Unique Protocol Identification Number
NCT01432639
Brief Title
Effects of Exercise Training on Endothelial Function, Inflammation, Arterial Stiffness and Autonomic Function in CAD
Official Title
Effects of Exercise Training on Endothelial Function, Inflammation, Arterial Stiffness and Autonomic Function in Coronary Artery Disease Patients
Study Type
Interventional
2. Study Status
Record Verification Date
June 2013
Overall Recruitment Status
Completed
Study Start Date
May 2011 (undefined)
Primary Completion Date
November 2012 (Actual)
Study Completion Date
November 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universidade do Porto
Collaborators
Centro Hospitalar de Vila Nova de Gaia/Espinho, Research Center in Physical Activity, Health and Leisure, Portugal
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The main purposes of this study is to analyze, in a randomized controlled trial, the effects of an exercise-based cardiac rehabilitation program (i) on biomarkers of endothelial function, (ii) on biomarkers of inflammation, (iii) on autonomic function, and (iv) on arterial stiffness in coronary artery disease patients (CAD). Additionally, the investigators aim to analyze the (v) contribution of age and the changes in traditional risk factors to the modification of the endothelial dysfunction and inflammation, and (vi) the contribution of the changes in inflammatory and endothelial function biomarkers to the modification of autonomic function and arterial stiffness.
The investigators hypothesize that exercise training will improve the autonomic function, arterial stiffness and mitigate the endothelial dysfunction and inflammation in CAD patients even in the absence of significant changes in traditional risk factors. Thus, the investigators expect with the present study to promote, develop and expand the knowledge in this field by assessing the impact of exercise on a pool of markers that provide a wide picture of the pathophysiological processes underlying CAD.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease
Keywords
Myocardial infarction, Autonomic function, Arterial Stiffness, Endothelial function, Inflammation, Rehabilitation program, Exercise
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
96 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Experimental group
Arm Type
Experimental
Arm Description
Patients undergoing the exercise-based cardiac rehabilitation program (intervention)
Arm Title
Control group
Arm Type
No Intervention
Arm Description
Usual medical care
Intervention Type
Other
Intervention Name(s)
Exercise-based cardiac rehabilitation program
Other Intervention Name(s)
Cardiac rehabilitation program
Intervention Description
The intervention consists of usual medical care (i.e., medicine prescription and counseling of lifestyle modifications) and an supervised outpatient aerobic exercise training, which will be performed 3 days per week for 8 weeks. Each exercise session include 10 min of warm up, 35 min of aerobic exercise (i.e., cycloergometer or treadmill) and 10 min of cool down. The exercise intensity will be calculated as 65- 75% of maximal heart rate achieved in the treadmill exercise testing. Individualized exercise prescription will be periodically adjusted. A perceived exertion scale will be used as an adjunctive intensity modulator. In addition, each patient will be encouraged to daily exercise outside the formal exercise program.
Primary Outcome Measure Information:
Title
Autonomic Function
Description
Autonomic function will be assessed by resting heart rate variability, heart rate recovery after maximal exercise and circulating levels of norepinephrine and epinephrine.
Time Frame
Change from Baseline in Autonomic Function at 8 weeks of Cardiac Rehabilitation Program
Secondary Outcome Measure Information:
Title
Arterial Stiffness
Description
Arterial Stiffness will be assessed by carotid-femoral pulse wave velocity and the aortic augmentation index.
Time Frame
Change from Baseline in Arterial Stiffness at 8 weeks of Cardiac Rehabilitation Program
Title
Endothelial Function
Description
Using commercially available assay kits (R&D Systems, Minneapolis, MN, USA), the serum levels of sICAM-1 and sVCAM-1 will be measured in serum by an enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions and read at 450 nm using a microplate reader (Labsystems iEMS MF controlled by Ascent software v. 2.4, Dynex Labsystems).
Time Frame
Change from Baseline in Endothelial Function at 8 weeks of Cardiac Rehabilitation Program
Title
Cardiorespiratory Fitness
Description
Maximal or symptom-limited treadmill exercise testing will be conducted using the modified Bruce protocol.
Time Frame
Change from Baseline in Cardiorespiratory Fitness at 8 weeks of Cardiac Rehabilitation Program
Title
Inflammatory Biomarkers
Description
Using commercially available assay kits (R&D Systems, Minneapolis, MN, USA), the serum levels of CRP, IL-10 and IL-6 will be measured in serum by an enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions and read at 450 nm using a microplate reader (Labsystems iEMS MF controlled by Ascent software v. 2.4, Dynex Labsystems).
Time Frame
Change from Baseline in Inflammatory Biomarkers at 8 weeks of Cardiac Rehabilitation Program
Title
Anthropometrics
Description
Height and weight measurements will be assessed using a standard wall-mounted stadiometer and portable digital beam scale (SECA, 708), respectively. Body mass index will be calculated from the ratio of weight (kg) to squared height (m2). Percentage of fat mass will be estimated by bioelectrical impedance analysis (BC-532, Tanita, Tokyo, Japan).
Time Frame
Change from Baseline in Anthropometrics at 8 weeks of Cardiac Rehabilitation Program
Title
Blood Pressure
Description
Resting systolic and diastolic blood pressure will be measured using a digital automatic blood pressure monitor (Omron Pressmate BP10, Omron Healthcare Co., Ltd, Kyoto, Japan).
Time Frame
Change from Baseline in Blood Pressure at 8 weeks of Cardiac Rehabilitation Program
Title
Dietary Intake
Description
Dietary intake will be assessed using a 4-day food diary as representative of the usual intake. Patients will be asked to provide detailed information concerning the food and beverages intake for four days (Sunday and 3-week days).
Time Frame
Change from Baseline in Dietary Intake at 8 weeks of Cardiac Rehabilitation Program
Title
Daily Physical Activity
Description
Physical activity will be objectively measured for 7 consecutive days using the ActiGraph accelerometer (model GT1M, Florida, USA).
Time Frame
Change from Baseline in Daily Physical Activity at 8 weeks of Cardiac Rehabilitation Program
Title
Biochemical Parameters
Description
Fasting plasma glucose, total cholesterol, high-density lipoprotein cholesterol, triglycerides, and HbA1c will be measured by enzymatic methods (912 automatic analyzer, Roche Diagnostic, Basel, Switzerland). Low-density lipoprotein cholesterol will be calculated using the Friedewald equation, except if triglycerides > 400 mg/dL.
Time Frame
Change from Baseline in Biochemical Parameters at 8 weeks of Cardiac Rehabilitation Program
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
acute myocardial infarction
Exclusion Criteria:
ventricular tachyarrhythmia
uncontrolled hypertension (systolic blood pressure >180 mmHg or diastolic blood pressure >100 mmHg)
significant valvular disease
unstable angina pectoris
reduced left ventricular function (ejection fraction < 45%)
abnormal hemodynamic response
myocardial ischemia and/or severe ventricular arrhythmias during baseline exercise testing
uncontrolled metabolic disease (e.g. uncontrolled diabetes or thyroid disease)
presence of pulmonary and renal co-morbidities
peripheral artery disease and/or orthopedic limitations
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jose Oliveira, PhD
Organizational Affiliation
Research Center in Physical Activity, Health and Leisure, Portugal
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Fernando Ribeiro, PhD
Organizational Affiliation
Research Center in Physical Activity, Health and Leisure, Portugal
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Nórton L Oliveira, MSc
Organizational Affiliation
Research Center in Physical Activity, Health and Leisure, Portugal
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Madalena Teixeira, MD
Organizational Affiliation
Centro Hospitalar de Vila Nova de Gaia/Espinho
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centro Hospitalar de Vila Nova de Gaia/Espinho
City
Vila Nova de Gaia
ZIP/Postal Code
4434-502
Country
Portugal
12. IPD Sharing Statement
Citations:
PubMed Identifier
19896741
Citation
Ribeiro F, Alves AJ, Duarte JA, Oliveira J. Is exercise training an effective therapy targeting endothelial dysfunction and vascular wall inflammation? Int J Cardiol. 2010 Jun 11;141(3):214-21. doi: 10.1016/j.ijcard.2009.09.548. Epub 2009 Nov 6.
Results Reference
background
PubMed Identifier
12176949
Citation
Graham LN, Smith PA, Stoker JB, Mackintosh AF, Mary DA. Time course of sympathetic neural hyperactivity after uncomplicated acute myocardial infarction. Circulation. 2002 Aug 13;106(7):793-7. doi: 10.1161/01.cir.0000025610.14665.21.
Results Reference
background
PubMed Identifier
20861747
Citation
Laing ST, Gluckman TJ, Weinberg KM, Lahiri MK, Ng J, Goldberger JJ. Autonomic effects of exercise-based cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2011 Mar-Apr;31(2):87-91. doi: 10.1097/HCR.0b013e3181f1fda0.
Results Reference
background
PubMed Identifier
17285225
Citation
Sandercock GR, Grocott-Mason R, Brodie DA. Changes in short-term measures of heart rate variability after eight weeks of cardiac rehabilitation. Clin Auton Res. 2007 Feb;17(1):39-45. doi: 10.1007/s10286-007-0392-5. Epub 2007 Feb 6.
Results Reference
background
PubMed Identifier
16183688
Citation
Weber T, Auer J, O'rourke MF, Kvas E, Lassnig E, Lamm G, Stark N, Rammer M, Eber B. Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventions. Eur Heart J. 2005 Dec;26(24):2657-63. doi: 10.1093/eurheartj/ehi504. Epub 2005 Sep 23.
Results Reference
background
PubMed Identifier
15177529
Citation
Edwards DG, Schofield RS, Magyari PM, Nichols WW, Braith RW. Effect of exercise training on central aortic pressure wave reflection in coronary artery disease. Am J Hypertens. 2004 Jun;17(6):540-3. doi: 10.1016/j.amjhyper.2003.12.001.
Results Reference
background
PubMed Identifier
17489343
Citation
Psychari SN, Apostolou TS, Iliodromitis EK, Kourakos P, Liakos G, Kremastinos DT. Inverse relation of C-reactive protein levels to heart rate variability in patients after acute myocardial infarction. Hellenic J Cardiol. 2007 Mar-Apr;48(2):64-71.
Results Reference
background
PubMed Identifier
15827047
Citation
Chesterton LJ, Sigrist MK, Bennett T, Taal MW, McIntyre CW. Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Nephrol Dial Transplant. 2005 Jun;20(6):1140-7. doi: 10.1093/ndt/gfh808. Epub 2005 Apr 12.
Results Reference
background
PubMed Identifier
25602857
Citation
Oliveira NL, Ribeiro F, Silva G, Alves AJ, Silva N, Guimaraes JT, Teixeira M, Oliveira J. Effect of exercise-based cardiac rehabilitation on arterial stiffness and inflammatory and endothelial dysfunction biomarkers: a randomized controlled trial of myocardial infarction patients. Atherosclerosis. 2015 Mar;239(1):150-7. doi: 10.1016/j.atherosclerosis.2014.12.057. Epub 2015 Jan 14.
Results Reference
derived
PubMed Identifier
24766987
Citation
Oliveira NL, Ribeiro F, Teixeira M, Campos L, Alves AJ, Silva G, Oliveira J. Effect of 8-week exercise-based cardiac rehabilitation on cardiac autonomic function: A randomized controlled trial in myocardial infarction patients. Am Heart J. 2014 May;167(5):753-61.e3. doi: 10.1016/j.ahj.2014.02.001. Epub 2014 Feb 17.
Results Reference
derived
Learn more about this trial
Effects of Exercise Training on Endothelial Function, Inflammation, Arterial Stiffness and Autonomic Function in CAD
We'll reach out to this number within 24 hrs